Related Experiment Videos
BCL2 expression correlates with metastatic potential in pancreatic cancer cell lines
R J Bold1, S Virudachalam, D J McConkey
1Department of Surgery, University of California Davis, Sacramento, California, USA. richard.bold@ucdmc.ucdavis.edu
Background:
Programmed cell death (termed apoptosis) regulates normal tissue homeostasis. Loss of local paracrine signals and intercellular adhesion molecules are potent inducers of apoptosis and thereby eliminate normal cells that may have escaped beyond the confines of the local organ environment. Dysregulation in the expression of the BCL2 gene family, the prototypic regulators of apoptosis, is a common occurrence in cancer and imparts resistance to standard triggers of apoptosis. Therefore, the authors sought to examine whether abnormal BCL2 gene family expression correlated with resistance to apoptosis and increased metastatic potential in pancreatic carcinoma.
Methods:
The authors examined BCL2 expression and apoptotic sensitivity in three panels of human pancreatic cancer cell lines that possess varying metastatic potential. Stable transfectants were generated that overexpress BCL2. These transfectants were then analyzed for differences in metastasis formation in athymic mice.
Results:
Among the isogenic panels of pancreatic cancer cell lines, BCL2 expression levels correlated with metastatic potential. Highly metastatic variants of each family of cell lines were more resistant to induction of apoptosis. Finally, using the BCL2 transfectant in a xenograft model, elevated BCL2 expression led to a higher incidence of metastases.
Conclusions:
The authors conclude that increased BCL2 expression correlates with apoptotic resistance and metastatic potential; dysregulation of BCL2 expression may be involved in the metastatic progression of pancreatic carcinoma.
Insights
Increased BCL2 gene expression in pancreatic cancer cells correlates with resistance to apoptosis and higher metastatic potential. This suggests BCL2 dysregulation may drive pancreatic cancer metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Programmed cell death (apoptosis) maintains tissue homeostasis.
- Dysregulation of the BCL2 gene family is common in cancer, conferring resistance to apoptosis.
- Pancreatic carcinoma progression may involve altered BCL2 expression.
Purpose of the Study:
- To investigate the correlation between BCL2 gene family expression and apoptosis resistance.
- To determine if BCL2 dysregulation is linked to increased metastatic potential in pancreatic cancer.
Main Methods:
- Assessed BCL2 expression and apoptotic sensitivity in human pancreatic cancer cell lines with varying metastatic capabilities.
- Created stable cell lines overexpressing BCL2.
- Evaluated metastasis formation in athymic mice using these BCL2-overexpressing cells.
Main Results:
- BCL2 expression levels positively correlated with metastatic potential across different pancreatic cancer cell line panels.
- Highly metastatic cell lines exhibited increased resistance to apoptosis induction.
- Elevated BCL2 expression in a xenograft model resulted in a greater incidence of metastasis.
Conclusions:
- Increased BCL2 expression is associated with resistance to apoptosis and enhanced metastatic potential in pancreatic cancer.
- Aberrant BCL2 expression may play a significant role in the metastatic progression of pancreatic carcinoma.